PBT 0.00% 0.0¢ prana biotechnology limited

Ann: Half Yearly Report and Accounts, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 139 Posts.
    lightbulb Created with Sketch. 4
    • ReleaseDate:28/02/1916:50
    • Summary:HalfYearlyReportandAccounts
    • PriceSensitive:Yes
    • ViewDocument
    "Review of operations-31December2018(continued)

    Pipeline development from Translational Biology Program Continued progress has been made on identifying new development candidates by Prana’s discovery chemistry group over the reporting period. These product candidates are within new generation chemical scaffolds and have demonstrated key attributes required to address neurodegenerative processes.

    Prana continues to review other potentially suitable opportunities that may be highly attractive and can add significant shareholder value in the medium to longer term. "

    Would the last sentence (which I have bolded) be a reference to the University of Qld paper?

 
watchlist Created with Sketch. Add PBT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.